| 書目名稱 | Tamoxifen |
| 副標題 | Pioneering Medicine |
| 編輯 | Philipp Y. Maximov,Russell E. McDaniel,V. Craig Jo |
| 視頻video | http://file.papertrans.cn/901/900540/900540.mp4 |
| 概述 | The story of Tamoxifen written first-hand by the "father of tamoxifen".A personal journey through four decades of discovery that changed women’s health.Including an interview with the pioneer of the t |
| 叢書名稱 | Milestones in Drug Therapy |
| 圖書封面 |  |
| 描述 | .Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years..This monograph, written by V. Craig Jordan - known as the “father of tamoxifen” - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a “failed morning after contraceptive” to become the “gold standard” for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen’s pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis.. |
| 出版日期 | Book 2013 |
| 關鍵詞 | Anti-estrogens; Apoptosis; Breast cancer; Estrogen receptor; SERMs |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-0348-0664-0 |
| isbn_softcover | 978-3-0348-0783-8 |
| isbn_ebook | 978-3-0348-0664-0Series ISSN 2296-6056 Series E-ISSN 2296-6064 |
| issn_series | 2296-6056 |
| copyright | Springer Basel 2013 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-5 23:30
發(fā)表于 2025-3-21 17:03:41
